deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT01930461

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

A Dose Ranging Study Investigating the Efficacy and Safety of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adults With House Dust Mite-associated Allergic Asthma

Sponsor: Stallergenes Greer

Conditions Asthma House Dust Mite Allergy
Interventions Placebo matching the SLIT tablets of HDM allergen extracts SLIT tablets of HDM allergen extracts, 3 different doses (A) SLIT tablets of HDM allergen extracts, 3 different doses (B) SLIT tablets of HDM allergen extracts, 3 different doses (C)
Updated 7 times since 2017 Last updated: Dec 17, 2015 Started: Sep 30, 2013 Primary completion: Jun 30, 2015 Completion: Aug 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Asthma and House Dust Mite Allergy and is currently completed. Stallergenes Greer leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotCompleted~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 2 earlier versions

  1. Aug 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Jan 2017 — Aug 2017 [monthly]

    Completed PHASE2

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Stallergenes Greer
Data source: Stallergenes Greer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations